Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Barin

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Revue Medicale Suisse|February 7, 2019
Claude Vaney, Laura Barin, Viktor Von Wyl
Multiple Sclerosis and Related Disorders|April 15, 2018
Recommended outcome measures for inpatient rehabilitation of multiple sclerosis are not appropriate for the patients with substantially impaired mobilityLaura Barin, Claude Vaney, Milo Alan Puhan, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 28, 2020
Long-term worsening of different body functions in persons with progressive multiple sclerosisMarco Kaufmann, Claude Vaney, Laura Barin, et al.
Plos One|April 20, 2023
Structural equation modeling (SEM) of kidney function markers and longitudinal CVD risk assessmentRyosuke Fujii, Roberto Melotti, Martin Gögele, et al.
Movement Disorders Clinical Practice|September 5, 2024
Archimedes Spiral Ratings: Determinants and Population-Based Limits of NormalFranziska Hopfner, Anja Tietz, Yuri D'Elia, et al.
Pathogens and Global Health|March 30, 2023
Determinants of SARS-CoV-2 nasopharyngeal testing in a rural community sample susceptible of first infection: the CHRIS COVID-19 studyDaniele Giardiello, Roberto Melotti, Giulia Barbieri, et al.
BMJ Open|June 8, 2023
Trends and symptoms of SARS-CoV-2 infection: a longitudinal study on an Alpine population representative sampleGiulia Barbieri, Massimo Pizzato, Martin Gögele, et al.
Multiple Sclerosis and Related Disorders|July 31, 2018
The disease burden of Multiple Sclerosis from the individual and population perspective: Which symptoms matter most?Laura Barin, Anke Salmen, Giulio Disanto, et al.
Plos One|June 24, 2025
Systematic mediation and interaction analyses of kidney function genetic loci in a general population studyDariush Ghasemi-Semeskandeh, David Emmert, Eva König, et al.
Journal of Nephrology|November 27, 2024
Development and evaluation of a kidney health questionnaire and estimates of chronic kidney disease prevalence in the Cooperative Health Research in South Tyrol (CHRIS) studyGiulia Barbieri, Lucia Cazzoletti, Roberto Melotti, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Revue Medicale Suisse|February 7, 2019
Claude Vaney, Laura Barin, Viktor Von Wyl
Multiple Sclerosis and Related Disorders|April 15, 2018
Recommended outcome measures for inpatient rehabilitation of multiple sclerosis are not appropriate for the patients with substantially impaired mobilityLaura Barin, Claude Vaney, Milo Alan Puhan, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 28, 2020
Long-term worsening of different body functions in persons with progressive multiple sclerosisMarco Kaufmann, Claude Vaney, Laura Barin, et al.
Plos One|April 20, 2023
Structural equation modeling (SEM) of kidney function markers and longitudinal CVD risk assessmentRyosuke Fujii, Roberto Melotti, Martin Gögele, et al.
Movement Disorders Clinical Practice|September 5, 2024
Archimedes Spiral Ratings: Determinants and Population-Based Limits of NormalFranziska Hopfner, Anja Tietz, Yuri D'Elia, et al.
Pathogens and Global Health|March 30, 2023
Determinants of SARS-CoV-2 nasopharyngeal testing in a rural community sample susceptible of first infection: the CHRIS COVID-19 studyDaniele Giardiello, Roberto Melotti, Giulia Barbieri, et al.
BMJ Open|June 8, 2023
Trends and symptoms of SARS-CoV-2 infection: a longitudinal study on an Alpine population representative sampleGiulia Barbieri, Massimo Pizzato, Martin Gögele, et al.
Multiple Sclerosis and Related Disorders|July 31, 2018
The disease burden of Multiple Sclerosis from the individual and population perspective: Which symptoms matter most?Laura Barin, Anke Salmen, Giulio Disanto, et al.
Plos One|June 24, 2025
Systematic mediation and interaction analyses of kidney function genetic loci in a general population studyDariush Ghasemi-Semeskandeh, David Emmert, Eva König, et al.
Journal of Nephrology|November 27, 2024
Development and evaluation of a kidney health questionnaire and estimates of chronic kidney disease prevalence in the Cooperative Health Research in South Tyrol (CHRIS) studyGiulia Barbieri, Lucia Cazzoletti, Roberto Melotti, et al.
Pageof 2